Pages that link to "Q39846072"

The following pages link to Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death (Q39846072):

Displaying 38 items.

• Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes (Q27932080) (← links)
• Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells (Q28118642) (← links)
• In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis. (Q33772734) (← links)
• Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells (Q34795775) (← links)
• Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First? (Q35412397) (← links)
• Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. (Q35690343) (← links)
• Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain (Q36469322) (← links)
• DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity (Q36801715) (← links)
• Up-regulation of SNCA gene expression: implications to synucleinopathies (Q37004246) (← links)
• Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival (Q37347595) (← links)
• The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). (Q37502964) (← links)
• scyllo-Inositol promotes robust mutant Huntingtin protein degradation (Q37563551) (← links)
• Treatment strategies for Parkinson's disease (Q37681312) (← links)
• KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species. (Q37716380) (← links)
• Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug? (Q37886152) (← links)
• α-Synuclein in Parkinson's disease (Q37987146) (← links)
• Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies (Q38000327) (← links)
• Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells (Q38757787) (← links)
• The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity (Q38968679) (← links)
• Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression (Q39039315) (← links)
• N‐terminal deletion does not affect α‐synuclein membrane binding, self‐association and toxicity in human neuroblastoma cells, unlike yeast (Q39489133) (← links)
• Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity. (Q40358428) (← links)
• Familial Parkinson's Disease Mutant E46K α-Synuclein Localizes to Membranous Structures, Forms Aggregates, and Induces Toxicity in Yeast Models (Q40579299) (← links)
• Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway (Q42368640) (← links)
• Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and Toxicity. (Q46119614) (← links)
• Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells (Q46488331) (← links)
• Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity. (Q47099565) (← links)
• Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy (Q47348189) (← links)
• Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein (Q48195020) (← links)
• Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. (Q51732455) (← links)
• Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease. (Q52609727) (← links)
• ELISA method to detect α-synuclein oligomers in cell and animal models. (Q55024134) (← links)
• Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients (Q64110558) (← links)
• Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells (Q89768995) (← links)
• Patient Semi-specific Computational Modeling of Electromagnetic Stimulation Applied to Neuroprotective Treatments in Acute Ischemic Stroke (Q89791033) (← links)
• Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models (Q90219888) (← links)
• Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons (Q91286539) (← links)
• Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? (Q92008457) (← links)